Jason Mark

Jason Mark, born New York, New York, August 22, 1967.

Admitted to bar: 1992, Florida; 1994, U.S. District Court, Southern District of Florida; 1995, Massachusetts; 1996, U.S. District Court, District of Massachusetts; 1998, U.S. Court of Appeals, Eleventh Circuit; 2000, New York; 2005, U.S. District Court, Eastern District of New York; 2006, U.S. District Court, Western and Southern Districts of New York.

Education: State University of New York at Buffalo (B.A., 1989); Tulane University School of Law (J.D., cum laude, 1992).

Appointments: Co-lead counsel, In re: Ortho Evra Birth Control Patch Litigation, Case No. 275, Superior Court of New Jersey; Co-Chair, Plaintiff’s Science Committee, In re Ortho Evra Products Liability Litigation, MDL 1742; Co-Chair, ATLA Bausch & Lomb Contact Lens Solution Litigation Group, July 2006 – Present.

Professional Memberships: Association of Trial Lawyers of America (ATLA); Massachusetts Academy of Trial Attorneys; Academy of Florida Trial Attorneys.  Honors:  Recipient, Massachusetts Rising Stars Award for Plaintiff Personal Injury: Malpractice, May 2005, awarded by Law & Politics and Boston Magazine.

Publications/Presentations: Invited Speaker, “Ortho Evra Mass Tort Litigation”, Mass Torts Made Perfect, March 30, 2007, Las Vegas, Nevada; Faculty Member and Speaker, “Bausch & Lomb ReNu with MoistureLoc”, Protecting the Public:  Pharmaceutical and Medical Device Litigaiton, Association of Trial Lawyers of America, November 17-18, 2006, Las Vegas, Nevada; Invited Speaker, “Bausch & Lomb Contact Lens Solution Litigation:  Issues, Mechanisms and Strategy”, Mass Torts Made Perfect, October 12-13, 2006, Las Vegas, Nevada; Invited Speaker, “Contact Lens Solution Litigation Conference”, Harris Martin Publishing, July 26, 2006, Chicago, Illinois;  Invited Speaker, Pharmaceutical & Human Tissue Litigation Conference, Harris Martin Publishing, June 29-30, 2006, Charleston, South Carolina; “Science & Causation”, Association of Trial Lawyers of America Ortho Evra Litigation Group, May 12, 2006, Washington, DC;  Invited Speaker, “Ortho Evra: Hidden Hazards and Untold Truths”, Mass Torts Made Perfect, March 30-31, 2006, Miami Beach, Florida;  Invited Speaker, “Mealey’s Birth Control Patch Litigation Conference:  Analysis of the Medical Issues”, March 6, 2006, Los Angeles, California; Invited Speaker, “Ortho-Evra Birth Control Patch Litigation TeleConference”, Mass Torts Made Perfect, February 10, 2006;  Invited Speaker, “Ortho Evra Birth Control Patch:  Is this the Next Mass Tort?”, Mass Torts Made Perfect, November 18, 2005, Las Vegas, Nevada; Co-author, “The Ortho-Evra Birth Control Patch and Thrombotic Injuries:  What Patients and Physicians Needed to Know But Were Never Told”, Mealey’s Emerging Drugs and Devices, January 19, 2006, Volume 11, Issue #2;  Author, “HMO Liability:  Medical Decisions Made in the Corporate Boardroom”, 25 Massachusetts Lawyers Weekly 2323, June, 1997; “The Unfolding of the Breast Implant Saga:  Past, Present and Future”, ABA Litigation, Vol. 7, No. 2, December, 1993; Member, Board of Editors, Leader Publications, a division of New York Law Publishing: “Medical/Legal Aspects of Breast Implants”; “The Anticybersquatting Consumer Protection Act:  Pre-Internet Law in a Post-Internet World”, 29 Massachusetts Lawyers Weekly 1853, April 2001.

Practice Areas: Lead Counsel and Co-Counsel in cases involving catastrophic injuries and death nationwide; Mass Torts; Toxic Torts; Defective Drug Liability; Medical Malpractice; Defective Medical Devices; Products Liability; Class Actions; General Personal Injury Negligence Litigation.

 

Other News

  • Avandia to be removed from Pharmacies

    Avandia the widely prescribed type 2 diabetes drug has been linked to increased cardiovascular risks and the debate has carried on for nearly four years about whether or not the drug should be taken off the market, according to a recent WebMD news report. The FDA issued a safety alert about a possible association between Avandia and increased cardiovascular risks back in 2007. Starting November 2011, the type 2 diabetes drugs Avandia, Avandamet, and Avandaryl will no longer be available [...]

    Read more →

  • Metal Hip Manufactures Asked to Provide Patient Data

    Not too long ago, DePuy Orthopaedics, a division of Johnson & Johnson, recalled two popular hip replacements systems the ASR Hip Resurfacing System and the ASR XL Acetabular System. Depuy said the products were recalled because a high percentage of patients required revision surgery after experiencing pain. Depuy said that it sold 93,000 of these systems before they decided to stop selling them last year. Additionally, dozens of other patients who have had other hip replacements from other manufacturers, such [...]

    Read more →

  • Jury Orders Allergan to Pay $212 Million in Botox Case

    A Virginia man who claimed that injections of the wrinkle-diminishing Botox left him with brain damage has been awarded $212 million by manufacturer Allergan Inc. Douglas Ray Jr. said he was receiving the injections to relieve a hand tremor and writer’s cramp, a report in the Richmond-Times Dispatch said. Ray said that that Allergan failed to warn him that injections could trigger an autoimmune response leading to brain damage. Botox is a purified form of the poison botulinum and is [...]

    Read more →

  • Drug Manufacturers to Discontinue Infant Drops of Key Medicine

    According to a recently released Associated Press news report, Johnson & Johnson and other drug makers of cold and fever medications said that they will discontinue infant drops of medicines containing acetaminophen in an effort to avoid confusion that can lead to dangerous overdoses. The industry association for over-the-counter medicine companies said its members will begin phasing out the liquid drops later this year. After the transition is complete, companies will only sell a single formula for all children under [...]

    Read more →

  • Bisphosphonates Linked to Bone Fractures: Study

    Findings from a new Swedish study reveal that osteoporosis drugs known as bisphosphonates increase the risk of getting unusual thigh bone fractures, as experts have suspected, according to a recent WebMD news article. But these fractures are infrequent and the risk is small the study shows. When correctly prescribed, the overall benefit of the drugs preventing all types of fractures outweighs the risk of getting the unusual fractures, says study researcher Per Aspenberg, MD, PhD, a professor of orthopaedic surgery [...]

    Read more →

  • Babies Heart Defect linked to Crude Oil Chemical Exposure

    According to an April 30, 2001, AFP news report, babies exposed before birth to ethyl benzene, a toxic component in crude oil, may have a higher risk of developing congenital heart disease, US researchers announced. Another chemical used as an industrial metal degreasing agent, trichloroethylene (TCE), also boosted heart risks, said the research to be presented at the Pediatric Academic Societies annual meeting in Denver, Colorado. Congenital heart disease occurs when the heart is malformed before birth, and is the [...]

    Read more →

  • Toyota Announces New Floor Mat Interference Recall

    Once again, Toyota owners are being affected by a new recall due to floor mat interference. Presently, Toyota Motor Corp. is facing hundreds of lawsuits in the United States form vehicle owners or families who suffered personal injuries, wrongful deaths, or suffered financial losses, as a result of sticky gas pedals and floor mat interference, which may causes sudden unexpected acceleration. Since the end of 2009, Toyota has recalled nearly 4 million vehicles in the United States due to sticky [...]

    Read more →

  • Lawsuit over Seat Belts Can Proceed

    According to a recent Reuters news report, The U.S. Supreme Court ruled that federal regulations setting vehicle safety standards do not bar lawsuits seeking damages from automakers for installing lap-only seat belts. The unanimous ruling held that a California lawsuit against Mazda Motor Corp over a fatal 2002 collision involving a 1993 Mazda minivan can proceed. A passenger sitting in a rear seat and wearing a lap-only seat belt was killed. The lawsuit by the family of the passenger claimed [...]

    Read more →